tradingkey.logo

CalciMedica Announces Discontinuation Of Phase 2 Kourage Trial In Aki Following Independent Data Monitoring Committee Recommendation

ReutersJan 28, 2026 12:05 PM

- CalciMedica Inc CALC.O:

  • CALCIMEDICA ANNOUNCES DISCONTINUATION OF PHASE 2 KOURAGE TRIAL IN AKI FOLLOWING INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDATION

  • CALCIMEDICA INC: SAFETY CONCERN WARRANTS REEVALUATION OF STUDY DESIGN, INCLUDING ENROLLMENT CRITERIA

  • CALCIMEDICA INC: POTENTIAL FUTURE TRIAL WITH AUXORA IN AKI TO BE EVALUATED AFTER DATA ANALYSIS

  • CALCIMEDICA INC - IDMC IDENTIFIES SAFETY CONCERN IN STUDY DESIGN

  • CALCIMEDICA INC: THERE WERE NO DEATHS IN TRIAL THAT WERE ASSESSED BY INVESTIGATORS OR CALCIMEDICA AS BEING RELATED TO STUDY DRUG

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI